There is an Act in the Health Committee of the NYS Senate which would require hospitals to offer the hep C Test to Baby Boomers… Introduced by A. Zebrowski
Learn more
Last Updated on January 25, 2020 by HepFree NYC
Related Articles
-
FDA Approves Viekira Pak to Treat Hep C
FDA Approves Viekira Pak to Treat Hep C A new hepatitis C medication, Viekira Pak, was approved today by the U.S. Food and Drug Administration (FDA). AbbVie, who markets the drug, has not immediately released the price of the new all-oral Hep C medication which will now rival Ha...
-
Get on the phone! & tell Congress to attend hepatitis briefing on July 26th
On Thursday, July 26th, the Caring Ambassadors Program and NVHR are hosting a briefing on behalf of the Congressional Hepatitis Caucus on the hepatitis B and C epidemics for Members of Congress and their staff. This briefing is part of the Caucus’ ongoing efforts to highlight t...
-
Article | Causes of Death among People with Hepatitis C in NYC, 2000‐2011
Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC DOHMH)
-
World Hepatitis Day – NYC 2016
On World Hepatitis Day 2016, hundreds of New Yorkers participated in educational forums, social media campaigns and free hepatitis screenings.
-
CDC Viral Hepatitis Strategic Plan – 2020
This Plan updates the Center’s current strategic plan and serves as a blueprint for achieving our vision of a future free of HIV, viral hepatitis, STDs, and TB.
-
NYS Medicaid Removes Hep C Experienced Provider Requirement from Prior Authorization Criteria
NYS Medicaid Removes Hep C Experienced Provider Requirement from Prior Authorization Criteria
-
Tell your story! How are rising med prices affecting your health? (American Medical Association)
The American Medical Association launched a website for consumers to tell their stories of how rising prices are affecting their health and their pocketbooks.
-
Study | Chronically infected Hep B Patients needed to donate plasma ($200)
Access Biologicals is currently in need of participants that diagnosed as acute or chronically infected with Hepatitis B. Access Biologicals supports diagnostic research & development of in-vitro diagnostics.
